GlassScriptPhysician profile
Nathan M Segerson
NPI 1841303534
$3,015.05
in general payments reported to CMS, 2019-2025
18 companies · $1,067 in 2025
The $1,067 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $392 · 2021: $164 · 2022: $177 · 2023: $34.94 · 2024: $551 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,652.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $991.67 | 2019-2025 | Aveir, Ensite, Gallant |
| Boston Scientific Corporation | $754.32 | 2019-2025 | General - Brady, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $374.91 | 2025 | Carto 3 |
| Medtronic, INC. | $142.53 | 2022-2025 | Affera Mapping System, Pulseselect |
| Edwards Lifesciences Corporation | $139.18 | 2024 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $136.64 | 2020-2022 | |
| Cordis US Corp. | $84.23 | 2024 | Mynx Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.07 | 2019-2020 | |
| Pfizer INC. | $58.22 | 2025 | |
| Impulse Dynamics (USA) INC. | $56.51 | 2024 | Optimizer |
| Medtronic Vascular, INC. | $52.65 | 2019 | |
| Angiodynamics, INC. | $49.78 | 2020 | |
| Kestra Medical Technology Services, INC. | $30.68 | 2025 | Assure Wcd |
| Terumo Medical Corporation | $24.32 | 2019 | |
| Merck Sharp & Dohme LLC | $16.16 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $13.25 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Covidien LP | $12.43 | 2019 | |
| Cardiovascular Systems INC. | $6.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Segerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.